Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discuss timing signals for reducing SP 500 in retirement portfolios, with risk considerations and withdrawal planning implications.
17,570 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Delek Logistics Partners has logged 13 years of rising payouts, but 2025 cash flow barely covers distributions, promp...
Tether has hired its first full independent audit from a Big Four firm, marking a major step toward transparency afte...
Citi trims its price target for Super Micro Computer to $25 from $39, citing governance and export-control concerns e...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
Better Home & Finance and Coinbase rolled out a crypto-backed conforming mortgage option that lets qualified borrower...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...
A senior House Democrat is pressing the Federal Reserve Bank of Kansas City for full details on Kraken’s master accou...
XRP trades in a narrow range as three big headwinds keep gains at bay. Analysts flag Bitcoin correlation, whale selli...
Grab stock has faced a meaningful pullback, prompting many investors to ask whether a dip presents a buying opportuni...
President Trump issues an emergency payroll directive for TSA workers as the DHS shutdown drags on, hoping to relieve...